Create your Clinical trial agreement Canada Form from scratch

Start Building Now
Title decoration

Here's how it works

01. Start with a blank Clinical trial agreement Canada Form
Open the blank document in the editor, set the document view, and add extra pages if applicable.
02. Add and configure fillable fields
Use the top toolbar to insert fields like text and signature boxes, radio buttons, checkboxes, and more. Assign users to fields.
03. Distribute your form
Share your Clinical trial agreement Canada Form in seconds via email or a link. You can also download it, export it, or print it out.

A brief guide on how to build a professional-looking Clinical trial agreement Canada Form

Form edit decoration

Step 1: Sign in to DocHub to create your Clinical trial agreement Canada Form.

First, log in to your DocHub account. If you don't have one, you can simply register for free.

Step 2: Go to the dashboard.

Once logged in, head to your dashboard. This is your main hub for all document-focused processes.

Step 3: Launch new document creation.

In your dashboard, hit New Document in the upper left corner. Opt for Create Blank Document to design the Clinical trial agreement Canada Form from a blank slate.

Step 4: Incorporate template elements.

Add various items like text boxes, photos, signature fields, and other interactive areas to your template and designate these fields to intended users as necessary.

Step 5: Configure your form.

Refine your form by adding instructions or any other necessary tips using the text tool.

Step 6: Go over and modify the form.

Carefully check your created Clinical trial agreement Canada Form for any typos or needed adjustments. Utilize DocHub's editing capabilities to perfect your form.

Step 7: Share or export the form.

After completing, save your file. You can select to keep it within DocHub, transfer it to various storage platforms, or forward it via a link or email.

be ready to get more

Build your Clinical trial agreement Canada Form in minutes

Start creating now

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial.
QUALIFIED INVESTIGATOR UNDERTAKING An undertaking must be completed by the qualified investigator responsible for the conduct of the clinical trial at the site specified below. The completed undertaking must be retained by the clinical trial sponsor for a period of 25 years.
The IU is a legal document, in which the investigator commits to conduct the trial in ance to the applicable regulatory, ethical and Good Clinical Practice guidelines.
The Independent Theatre Agreement (ITA) is similar to the CTA but this agreement is used for professional theatre companies which are not members of PACT.
Clinical Trial Application ( CTA ) The CTA is composed of three parts (modules): Module 1 - contains administrative and clinical information about the proposed trial. Module 2 - contains Quality (Chemistry and Manufacturing) information about the drug product(s) to be used in the proposed trial.
be ready to get more

Build your Clinical trial agreement Canada Form in minutes

Start creating now

Related Q&A to Clinical trial agreement Canada Form

For a CTA, the four main documents are the protocol, informed consent form, IB, and Investigational Medicinal Product Dossier (IMPD), which contains CMC data. In addition to these, other documents such as EU-specific forms, questionnaires and insurance certificates must be included.
FDA Form 1572 for Canadian Sites FDA Form 1572 (Statement of Investigator) is a contract between the FDA and the clinical investigator. It states that the clinical investigator will: Conduct the study ing to the protocol. Personally conduct/supervise the study.
The Clinical Trial Site Information (CTSI) form is required to be submitted by clinical trial sponsors prior to initiating a protocol or implementing subsequent amendment(s) at the clinical trial site for trials that are subject to Division 5 of Part C of the Food and Drug Regulations or the Clinical Trials for Medical

Additional resources on building your forms